| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.25 | 0.1 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |